Separation of Cdc25 dual specificity phosphatase inhibition and DNA cleaving activities in a focused library of analogs of the antitumor antibiotic Dnacin

Peter Wipf, Corey R. Hopkins, Eleanor O. Phillips, John S. Lazo

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Biological evaluation of 96 analogs and synthetic intermediates of the naphthyridinomycin-type antitumor antibiotic Dnacin led to the identification of several low-micromolar inhibitors of dual specificity phosphatases, specifically Cdc25A1, Cdc25B2, and VHR, as well as the tyrosine phosphatase PTP1B. While the parent Dnacins are potent DNA cleavage agents, most of the analog structures, even those that retained significant phosphatase inhibitory activities, did not lead to plasmid DNA cleavage. Thus, the DNA-targeting and the phosphatase-inhibitory activities of Dnacins can be assigned to different pharmacophores.

Original languageEnglish (US)
Pages (from-to)6367-6372
Number of pages6
JournalTetrahedron
Volume58
Issue number32
DOIs
StatePublished - Aug 5 2002

Fingerprint

cdc25 Phosphatases
Dual-Specificity Phosphatases
Phosphoric Monoester Hydrolases
Libraries
DNA Cleavage
Anti-Bacterial Agents
DNA
Tyrosine
Plasmids
dnacins

Keywords

  • Cdc25
  • DNA cleavage
  • Dnacin
  • Dual specificity phosphatase inhibitors
  • Natural product library
  • PTP1B
  • SAR
  • Tyrosine phosphatase
  • VHR

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Cite this

Separation of Cdc25 dual specificity phosphatase inhibition and DNA cleaving activities in a focused library of analogs of the antitumor antibiotic Dnacin. / Wipf, Peter; Hopkins, Corey R.; Phillips, Eleanor O.; Lazo, John S.

In: Tetrahedron, Vol. 58, No. 32, 05.08.2002, p. 6367-6372.

Research output: Contribution to journalArticle

@article{3134ee38a31149c7a14d9bf322a0ee2c,
title = "Separation of Cdc25 dual specificity phosphatase inhibition and DNA cleaving activities in a focused library of analogs of the antitumor antibiotic Dnacin",
abstract = "Biological evaluation of 96 analogs and synthetic intermediates of the naphthyridinomycin-type antitumor antibiotic Dnacin led to the identification of several low-micromolar inhibitors of dual specificity phosphatases, specifically Cdc25A1, Cdc25B2, and VHR, as well as the tyrosine phosphatase PTP1B. While the parent Dnacins are potent DNA cleavage agents, most of the analog structures, even those that retained significant phosphatase inhibitory activities, did not lead to plasmid DNA cleavage. Thus, the DNA-targeting and the phosphatase-inhibitory activities of Dnacins can be assigned to different pharmacophores.",
keywords = "Cdc25, DNA cleavage, Dnacin, Dual specificity phosphatase inhibitors, Natural product library, PTP1B, SAR, Tyrosine phosphatase, VHR",
author = "Peter Wipf and Hopkins, {Corey R.} and Phillips, {Eleanor O.} and Lazo, {John S.}",
year = "2002",
month = "8",
day = "5",
doi = "10.1016/S0040-4020(02)00636-1",
language = "English (US)",
volume = "58",
pages = "6367--6372",
journal = "Tetrahedron",
issn = "0040-4020",
publisher = "Elsevier Limited",
number = "32",

}

TY - JOUR

T1 - Separation of Cdc25 dual specificity phosphatase inhibition and DNA cleaving activities in a focused library of analogs of the antitumor antibiotic Dnacin

AU - Wipf, Peter

AU - Hopkins, Corey R.

AU - Phillips, Eleanor O.

AU - Lazo, John S.

PY - 2002/8/5

Y1 - 2002/8/5

N2 - Biological evaluation of 96 analogs and synthetic intermediates of the naphthyridinomycin-type antitumor antibiotic Dnacin led to the identification of several low-micromolar inhibitors of dual specificity phosphatases, specifically Cdc25A1, Cdc25B2, and VHR, as well as the tyrosine phosphatase PTP1B. While the parent Dnacins are potent DNA cleavage agents, most of the analog structures, even those that retained significant phosphatase inhibitory activities, did not lead to plasmid DNA cleavage. Thus, the DNA-targeting and the phosphatase-inhibitory activities of Dnacins can be assigned to different pharmacophores.

AB - Biological evaluation of 96 analogs and synthetic intermediates of the naphthyridinomycin-type antitumor antibiotic Dnacin led to the identification of several low-micromolar inhibitors of dual specificity phosphatases, specifically Cdc25A1, Cdc25B2, and VHR, as well as the tyrosine phosphatase PTP1B. While the parent Dnacins are potent DNA cleavage agents, most of the analog structures, even those that retained significant phosphatase inhibitory activities, did not lead to plasmid DNA cleavage. Thus, the DNA-targeting and the phosphatase-inhibitory activities of Dnacins can be assigned to different pharmacophores.

KW - Cdc25

KW - DNA cleavage

KW - Dnacin

KW - Dual specificity phosphatase inhibitors

KW - Natural product library

KW - PTP1B

KW - SAR

KW - Tyrosine phosphatase

KW - VHR

UR - http://www.scopus.com/inward/record.url?scp=0037026007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037026007&partnerID=8YFLogxK

U2 - 10.1016/S0040-4020(02)00636-1

DO - 10.1016/S0040-4020(02)00636-1

M3 - Article

AN - SCOPUS:0037026007

VL - 58

SP - 6367

EP - 6372

JO - Tetrahedron

JF - Tetrahedron

SN - 0040-4020

IS - 32

ER -